...
| Name of Collection within TCIA | DOI of Collection in TCIA | NCTN Trial code | Form: Is an Entity Collaborative Agreement required? |
|---|---|---|---|
| ACNS0332 | 10.7937/TCIA.582B-XZ89 | NCT00392327 | no |
| ACNS0332-Tumor-Annotations Derived Collection | 10.7937/D8A8-6252 | NCT00392327 | no |
| AHEP0731 | 10.7937/F2DB-8826 | NCT00980460 | With |
| AHOD0831 | 10.7937/CV5M-1H59 | NCT01026220 | no |
| ARAR0331 | 10.7937/WTEC-MN22 | no | |
| AREN0532 | 10.7937/6PJ1-M859 | NCT00352534 | no |
| AREN0533 | 10.7937/SJEZ-CJ78 | NCT00379340 | no |
| AREN0534 | 10.7937/TCIA.5M9S-6Y97 | NCT00945009 | no |
| A091105 | 10.7937/0WF5-SJ50 | NCT02066181 | With |
| CALGB50303 | 10.7937/CM65-A013 | NCT00118209 | no |
| EA1141 | 10.7937/2BAS-HR33 | NCT02933489 | no |
| RTOG-0617 (NSCLC-Cetuximab) | 10.7937/TCIA.2018.jze75u7v | NCT00533949 | With |
| S0819 | 10.7937/DT39-JS04 | NCT00946712 | With |
...